Browsing Tag
LIFT-AD Trial
1 post
Athira Pharma completes patient dosing in Phase 2/3 trial of fosgonimeton in AD
Athira Pharma, Inc. (NASDAQ: ATHA), a prominent biopharmaceutical company specializing in neurodegenerative diseases, has announced the completion of…